Project Details
Description
Neurogenesis was traditionally believed to occur only during embryonic development in
mammals. Only recently has it become generally accepted that new neurons are indeed
continuously produced and integrated in discrete regions of the adult mammalian central nervous
system. Adult neurogenesis recapitulates the complete process of the neuronal development,
from fate specification of neural progenitors, migration, synaptic integration and maturation of
newborn dentate granule cells (DGCs). The molecular mechanisms that regulate these
neurogenesis steps are largely unknown. Gamma-aminbutyric acid (GABA), one of the major
inhibitory neurotransmitter in the adult central nervous system, activates GABA receptors in the
tonic/phasic mechanisms. Emerging evidence suggests that GABA receptor activity also plays an
essential role in regulating the adult neurogenesis. The specific contribution of tonic and/or
phasic GABA activation to the proliferation and differentiation of adult neural progenitors and
the synaptic integration of their progeny, however, is unknown, and will be examined in our
current proposal. Specific Aim I: To determine the roles of tonic GABA receptor activation in
regulating proliferation and fate specification of neural progenitors in the adult brain. Specific
Aim II: To examine the specific roles of tonic and/or phasic GABA receptor activation in
synapse formation and maturation of newborn DGCs in the adult brain. Specific Aim III: To
determine the roles of GABA receptor activation in the formation of functional synapses by the
axons of newborn DGCs in the adult brain. The approach will be to use engineered retroviruses
to genetically manipulate GABAergic activity of the adult neural progenitors and their progeny.
The proliferation and differentiation of these genetically-manipulated adult neural progenitors
and the synaptic integration of these newborn neurons will be examined. Understanding these
regulatory mechanisms for adult neurogenesis may provide clues into the etiology and pathology
of these brain disorders and diseases. More importantly, these studies may shed light on novel
therapy development such as functional replacement of damaged neurons in degenerative
neurological disease utilizing stem cells, including both embryonic stem cells and adult neural
stem cells.
| Status | Finished |
|---|---|
| Effective start/end date | 09/1/09 → 08/31/14 |
Funding
- National Inst of Neurological Disorders & Stroke: $1,435,153.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.